Connection

Galia Rahav to Antibodies, Neutralizing

Back to Details
This is a "connection" page, showing publications Galia Rahav has written about Antibodies, Neutralizing.
Galia Rahav
Connection Strength
0.120
Antibodies, Neutralizing
  1. Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies. Transplantation. 2021 11 01; 105(11):e234-e243.
    View in: PubMed
    Score: 0.034
  2. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clin Microbiol Infect. 2021 Dec; 27(12):1851-1855.
    View in: PubMed
    Score: 0.034
  3. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. Clin Infect Dis. 2018 08 16; 67(5):649-656.
    View in: PubMed
    Score: 0.027
  4. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 01 26; 376(4):305-317.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.